These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 1845465)

  • 1. Hyperlipidemia, dyslipoproteinemia and apolipoproteinopathia--classification and risk of atherosclerosis. Part 2: Hypercholesterolemia.
    Choluj B; Votruba T
    Acta Univ Carol Med (Praha); 1991; 37(3-4):106-15. PubMed ID: 1845465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperlipidemia, dyslipoproteinemia and apolipoproteinopathia--classification and risk of atheroslcerosis. Part I: Principles of classification and methods of dyslipoproteinemia determination.
    Choluj B; Votruba T; Kormúth E
    Acta Univ Carol Med (Praha); 1991; 37(3-4):91-105. PubMed ID: 1845469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The application of molecular biology techniques to the diagnosis of hyperlipidaemia and other risk factors for cardio-vascular disease.
    Humphries SE
    Ann Biol Clin (Paris); 1994; 52(1):67-75. PubMed ID: 8210077
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyperlipidemia, dyslipoproteinemia and apolipoproteinopathia--classification and risk of atherosclerosis. Part 3: Hypertriacylglycerolemia.
    Choluj B; Votruba T
    Acta Univ Carol Med (Praha); 1991; 37(3-4):116-28. PubMed ID: 1845466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperlipidemia, dyslipoproteinemia and apolipoproteinopathia--classification and risk of atherosclerosis. Part 4: Apolipoproteinopathia.
    Choluj B; Votruba T
    Acta Univ Carol Med (Praha); 1991; 37(3-4):129-40. PubMed ID: 1845467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperlipidemia, dyslipoproteinemia and apolipoproteinopathia--classification and risk of atherosclerosis. Part 5: Normolipidemic (latent) dyslipoproteinemia.
    Choluj B
    Acta Univ Carol Med (Praha); 1991; 37(3-4):141-55. PubMed ID: 1845468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and biochemical features of atherosclerosis main risk factors in children of probands with primary hyperlipidemia].
    Alidzhanova KhG; Tvorogova MG; Rozhkova TA; Balakhonova TV; Vorob'eva LP; Masenko VP; Kukharchuk VV
    Ter Arkh; 1998; 70(1):19-23. PubMed ID: 9532645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric aspects of familial hypercholesterolemias: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
    Daniels SR; Gidding SS; de Ferranti SD;
    J Clin Lipidol; 2011 Jun; 5(3 Suppl):S30-7. PubMed ID: 21600527
    [No Abstract]   [Full Text] [Related]  

  • 9. [Striatocapsular infarct in a young patient with heterozygous familial hypercholesterolemia and Klinefelter's syndrome].
    Perla C; Sánchez R; Alfaro A; Gilsanz A; Domínguez F
    Med Clin (Barc); 1993 Dec; 101(19):746-9. PubMed ID: 8289524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemorrheologic abnormalities in defined primary dyslipoproteinemias with both high and low atherosclerotic risks.
    Otto C; Ritter MM; Richter WO; Minkenberg R; Schwandt P
    Metabolism; 2001 Feb; 50(2):166-70. PubMed ID: 11229424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Screening and treatment of children and adolescents with hypercholesterolemias and dyslipidemias].
    Sobra J
    Cas Lek Cesk; 1998 Feb; 137(3):67-72. PubMed ID: 9511274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biochemical diagnosis of hereditary hyperlipoproteinemias].
    Tvorogova MG; Rozhkova TA; Alidzhanova KhG; Semenova OA; Sobolev AV; Kukharchuk VV; Titov VN
    Ter Arkh; 1998; 70(4):9-15. PubMed ID: 9612894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The treatment of familial hypercholesterolemia].
    Lansberg PJ; Kastelein JJ; Defesche JC; ten Cate JW
    Ned Tijdschr Geneeskd; 1992 Apr; 136(15):734-8. PubMed ID: 1560866
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diagnosis, clinical features and treatment of hyperlipidemias in children].
    Widhalm K
    Monatsschr Kinderheilkd; 1982 Oct; 130(10):747-52. PubMed ID: 7177116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypercholesterolemia and atherogenesis.
    Stehbens WE
    CMAJ; 1990 Apr; 142(8):799-801. PubMed ID: 2322906
    [No Abstract]   [Full Text] [Related]  

  • 16. [Xanthoma].
    Shiraishi S
    Ryoikibetsu Shokogun Shirizu; 1994; (4):203-5. PubMed ID: 8007132
    [No Abstract]   [Full Text] [Related]  

  • 17. [Secondary disorders of lipid metabolism, metabolic syndrome and familial combined hyperlipidemia].
    Steinmetz A; Schäfer JR
    Wien Med Wochenschr; 1994; 144(12-13):299-307. PubMed ID: 8650933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic hyperlipidemia and atherosclerosis.
    Stone NJ
    Artery; 1979 May; 5(5):377-97. PubMed ID: 262162
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hypercholesterolemia in children and young adults: should screening be done?].
    Keller U
    Schweiz Med Wochenschr; 1995 Feb; 125(7):255-63. PubMed ID: 7878403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical inquiries. When should we screen children for hyperlipidemia?
    Misicko NE; St Anna L; Foliaco W
    J Fam Pract; 2006 Aug; 55(8):723-5. PubMed ID: 16882449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.